RIGL

RIGL

USD

Rigel Pharmaceuticals Inc. Common Stock

$28.380-1.710 (-5.683%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$30.090

High

$30.795

Low

$28.080

Volume

0.31M

Company Fundamentals

Market Cap

509.1M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.71M

Exchange

NMS

Currency

USD

52-Week Range

Low $13.91Current $28.380High $43.72

Related News

PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...

View more
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
CNBC

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.

View more
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'
PR Newswire

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on...

View more
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update